304 related articles for article (PubMed ID: 31962340)
1. Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry.
Callis Duffin K; Mason MA; Gordon K; Harrison RW; Crabtree MM; Guana A; Germino R; Lebwohl M
Dermatology; 2021; 237(1):46-55. PubMed ID: 31962340
[TBL] [Abstract][Full Text] [Related]
2. Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry.
Strober B; Greenberg JD; Karki C; Mason M; Guo N; Hur P; Zhao Y; Herrera V; Lin F; Lebwohl M
BMJ Open; 2019 Apr; 9(4):e027535. PubMed ID: 31005939
[TBL] [Abstract][Full Text] [Related]
3. Association of Nail Psoriasis With Disease Activity Measures and Impact in Psoriatic Arthritis: Data From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Liu M; Rebello S; McLean RR; Dube B; Glynn M; Hur P; Ogdie A
J Rheumatol; 2021 Apr; 48(4):520-526. PubMed ID: 33060307
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry.
Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
J Rheumatol; 2017 Aug; 44(8):1151-1158. PubMed ID: 28620063
[TBL] [Abstract][Full Text] [Related]
5. Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Palmer JB; Liu M; Kavanaugh A; Pandurengan R; Ritchlin CT; Karki C; Greenberg JD
J Rheumatol; 2018 Oct; 45(10):1389-1396. PubMed ID: 29961691
[TBL] [Abstract][Full Text] [Related]
6. Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry.
Mease PJ; Palmer JB; Hur P; Strober BE; Lebwohl M; Karki C; Reed GW; Etzel CJ; Greenberg JD; Helliwell PS
J Eur Acad Dermatol Venereol; 2019 May; 33(5):886-892. PubMed ID: 30663130
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry.
Yu C; Wang G; Burge RT; Ye E; Dou G; Li J; Harrison RW; McLean RR; Kerti SJ; Bagel J
Dermatol Ther (Heidelb); 2023 Jan; 13(1):187-206. PubMed ID: 36385699
[TBL] [Abstract][Full Text] [Related]
8. Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands.
van den Reek JMPA; van der Leest RJT; Thomas SE; Prevoo R; Plantenga ME; de Jong EMGJ
Adv Ther; 2024 Apr; 41(4):1594-1605. PubMed ID: 38402373
[TBL] [Abstract][Full Text] [Related]
9. Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry.
Strober B; Karki C; Mason M; Guo N; Holmgren SH; Greenberg JD; Lebwohl M
J Am Acad Dermatol; 2018 Feb; 78(2):323-332. PubMed ID: 29051036
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in patients with generalized pustular psoriasis - a Swedish register study.
Norlin JM; Löfvendahl S; Schmitt-Egenolf M
Ann Med; 2024 Dec; 56(1):2341252. PubMed ID: 38738413
[TBL] [Abstract][Full Text] [Related]
11. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry.
Gottlieb AB; Merola JF; Cirulli J; Williams CC; Linowski GJ; Paris M; Litman HJ; Guo N; Emeanuru K; McLean RR; Cronin A; Strober B
Dermatol Ther (Heidelb); 2021 Feb; 11(1):253-263. PubMed ID: 33475970
[TBL] [Abstract][Full Text] [Related]
13. The Brigham Scalp Nail Inverse Palmoplantar Psoriasis Composite Index (B-SNIPI): a novel index to measure all non-plaque psoriasis subsets.
Patel M; Liu SW; Qureshi A; Merola JF
J Rheumatol; 2014 Jun; 41(6):1230-2. PubMed ID: 24882859
[TBL] [Abstract][Full Text] [Related]
14. Effect of Multidomain Disease Presentations on Patients With Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Ogdie A; Hur P; Liu M; Rebello S; McLean RR; Dube B; Glynn M; Mease PJ
J Rheumatol; 2021 May; 48(5):698-706. PubMed ID: 33004532
[TBL] [Abstract][Full Text] [Related]
15. Sustained High Efficacy and Favorable Safety Over Five Years in Patients With Burdensome Psoriasis (UNCOVER-1/UNCOVER-2).
Papp KA; Gerdes S; Leonardi CL; Elmaraghy H; See K; McKean-Matthews M; Konicek BW; Crane HM; Eastman W
J Drugs Dermatol; 2021 Aug; 20(8):880-887. PubMed ID: 34397207
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of apremilast in biologic-naïve patients with moderate psoriasis treated in routine clinical practice in Greece: the APRAISAL study.
Ioannides D; Antonakopoulos N; Georgiou S; Chasapi V; Katsantonis I; Drosos A; Rigopoulos D; Antoniou C; Anastasiadis G; Bassukas I; Ioannidou D; Protopapa A; Neofotistou O; Krasagakis K; Aronis P; Papageorgiou M; Lazaridou E; Patsatsi A; Lefaki I; Roussaki-Schulze AV; Satra F; Anagnostopoulos Z; Papakonstantis M
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1838-1848. PubMed ID: 34036627
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study.
Thaçi D; Unnebrink K; Sundaram M; Sood S; Yamaguchi Y
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):353-360. PubMed ID: 24846518
[TBL] [Abstract][Full Text] [Related]
18. Disease burden and treatment needs of patients with psoriasis in sexually-sensitive and visible body areas: results from a large-scale survey in routine care.
da Silva N; Augustin M; Langenbruch A; Mrowietz U; Reich K; Thaçi D; Boehncke WH; Kirsten N; Danckworth A; Sommer R
Eur J Dermatol; 2020 Jun; 30(3):267-278. PubMed ID: 32666927
[TBL] [Abstract][Full Text] [Related]
19. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
Spuls PI; Hooft L
Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
[TBL] [Abstract][Full Text] [Related]
20. Disease Characteristics, Quality of Life, and Work Productivity by Enthesitis Site: Real-world Data From the US Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Liu M; Rebello S; Hua W; McLean RR; Hur P; Ogdie A
J Rheumatol; 2021 Mar; 48(3):367-375. PubMed ID: 32482647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
